Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.
Hama N, Abe R, Gibson A, Phillips EJ.
J Allergy Clin Immunol Pract. 2022 May;10(5):1155-1167.e5. doi: 10.1016/j.jaip.2022.02.004. Epub 2022 Feb 15.
Clozapine-induced myocarditis: "Psychoanalysing" drug-induced myocarditis.
Savvatis K, Mohiddin SA.
Int J Cardiol. 2018 May 15;259:130-131. doi: 10.1016/j.ijcard.2018.02.071.
Acute Myocardial Infarction in Young Individuals.
Gulati R, Behfar A, Narula J, Kanwar A, Lerman A, Cooper L, Singh M.
Mayo Clin Proc. 2020 Jan;95(1):136-156. doi: 10.1016/j.mayocp.2019.05.001.
[Drug-induced myocarditis].
Takehana H, Izumi T.
Nihon Rinsho. 2007 Oct 28;65 Suppl 8:436-9.
Clozapine, mRNA COVID-19 vaccination and drug-induced myocarditis.
Dawson JL, Clark SR, Wilton LR, Chiew KY, Procter NG, Bell JS.
Aust N Z J Psychiatry. 2022 Jul;56(7):879. doi: 10.1177/00048674211062135. Epub 2021 Nov 30.
Drug-induced toxic myocarditis.
Ansari A, Maron BJ, Berntson DG.
Tex Heart Inst J. 2003;30(1):76-9.
[Mesalazine-induced myocarditis].
Koh Y, Nagaya T, Saegusa H, Ikeuchi H, Kodama R, Ushimaru H.
Nihon Shokakibyo Gakkai Zasshi. 2020;117(12):1093-1099. doi: 10.11405/nisshoshi.117.1093.
Drug-Induced Hypersensitivity Syndrome/Drug Reaction With Eosinophilia and Systemic Symptoms: Predictive Score and Outcomes.
Mizukawa Y, Hama N, Miyagawa F, Takahashi H, Ogawa Y, Kurata M, Asada H, Abe R, Shiohara T.
J Allergy Clin Immunol Pract. 2023 Oct;11(10):3169-3178.e7. doi: 10.1016/j.jaip.2023.06.065. Epub 2023 Jul 10.
The cellular mechanism of antipsychotic-induced myocarditis: A systematic review.
Vaziri N, Marques D, Greenway SC, Bousman CA.
Schizophr Res. 2023 Nov;261:206-215. doi: 10.1016/j.schres.2023.09.039. Epub 2023 Oct 3.
Drug-induced pseudolupus.
Grob PJ, Müller-Schoop JW, Häcki MA, Joller-Jemelka HI.
Lancet. 1975 Jul 26;2(7926):144-8. doi: 10.1016/s0140-6736(75)90055-0.
